Multi-Segmental Spinal Manual Therapy in Women With Episodic Migraine

NCT ID
NCT07774286
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Borna Farhoomand
Conditions
Migraine Disorders

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Multi-segmental Spinal Manual Therapy for Pain, Central Sensitization, and Sensorimotor Control in Women With Episodic Migraine: A Case Series.

Enrollment: 10 participants (Estimated).

What is being studied

  • Procedure: Multi-Segmental Spinal Manual Therapy

Who may be eligible

Ages
18 Years to 30 Years
Sex
Female
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Female patients aged 18-30 years, * Diagnosis of episodic migraine established by a specialist neurologist, * Headache frequency of \<15 days per month, * Pain intensity score of ≥40 mm on the Visual Analog Scale (VAS), * Absence of any diagnosed psychiatric disorders, * Literacy (ability to read and write), * Ability to communicate effectively without language or cognitive barriers, * Voluntary participation confirmed by signed written informed consent. Exclusion Criteria: * History of communication disorders or neuromusculoskeletal diseases that impede assessment procedures, * Headache frequency exceeding 15 days per month, * Diagnosis of other primary or secondary headache types (e.g., cervicogenic headache, tension-type headache), * Pregnancy, * Diagnosis of fibromyalgia syndrome or myofascial pain syndrome, * Diagnosis of systemic rheumatic diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), * Diagnosis or presence of symptoms related to spinal disc disorders (e.g., disc herniation, disc prolapse), * History of whiplash or similar cervical/head trauma, * Diagnosis or presence of symptoms associated with temporomandibular joint dysfunction (TMD), * Having received physical therapy within the last 3 months, * Having undergone anesthetic nerve block procedures within the last 6 months, * Receiving any prophylactic or interventional migraine therapy other than acute analgesics, * Self-reported history or presence of malignancy.

Study locations

No study locations are listed in the registry data.

Study details

Start date
September 1, 2026
Primary completion date
November 30, 2026
Completion date
December 30, 2026
First posted
August 19, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07774286
Registry last updated
August 25, 2026
QualifiedStudies registry data refreshed
October 5, 2026
QualifiedStudies record fetched
October 5, 2026

View NCT07774286 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Migraines studies | Clinical trial FAQ